bostongene

BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions

Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune BiologySAN…

2 weeks ago

BostonGene Receives Frost & Sullivan’s 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation

BostonGene's comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages…

6 months ago